330. 先天性気管狭窄症／先天性声門下狭窄症［先天性気管狭窄症（~2018.3）］
［臨床試験数：1，薬物数：3（DrugBank：2），標的遺伝子数：0，標的パスウェイ数：0］
Searched query = "Congenital tracheal stenosis / Congenital subglottic stenosis", "Congenital tracheal stenosis", "Congenital tracheal stenosis", "Congenital subglottic stenosis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | JPRN-JMA-IIA00357 | 01/07/2018 | 19/06/2018 | Phase II trial of helium / oxygen mixed gas for respiratory failure secondary to airway obstructive lesion in children | Phase II trial of helium / oxygen mixed gas for respiratory failure secondary to airway obstructive lesion in children | Respiratory failure due to airway obstructive lesion such as acute bronchiolitis, congenital tracheal stenosis, bronchial asthma attack | Intervention type:DRUG. Intervention1:Helium / oxygen mixed gas inhalation therapy, Dose form:INSUFFLATION, Route of administration:INHALATIONAL, intended dose regimen:Helium / oxygen mixed gas . | Tokyo Metropolitan Children's Medical Center | National Center for Child Health and Development | Recruiting | No Limit | <20 YEARS | BOTH | 15 | Phase 2 | Japan |